PCP
ALNY icon

Proficio Capital Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Proficio Capital Partners’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-488
Closed -$223K – 241
2025
Q3 		$223K Sell
488
-394
-45% -$160K 0.02% 210
2025
Q2 		$288K Buy
882
+74
+9% +$20.5K 0.02% 328
2025
Q1 		$218K Buy
+808
New +$208K 0.02% 354
2024
Q4 		– Sell
-744
Closed -$205K – 365
2024
Q3 		$205K Sell
744
-838
-53% -$218K 0.02% 271
2024
Q2 		$384K Sell
1,582
-464
-23% -$73.3K 0.04% 203
2024
Q1 		$306K Buy
+2,046
New +$341K 0.03% 240
2019
Q3 		– Sell
-74
Closed -$5K – 188
2019
Q2 		$5K Sell
74
-4
-5% -$307 ﹤0.01% 1183
2019
Q1 		$7K Buy
78
+2
+3% +$167 ﹤0.01% 987
2018
Q4 		$6K Sell
76
-26
-25% -$2K ﹤0.01% 814
2018
Q3 		$9K Hold
102
– – ﹤0.01% 817
2018
Q2 		$10K Buy
102
+40
+65% +$3.97K ﹤0.01% 817
2018
Q1 		$7K Buy
62
+24
+63% +$3.09K ﹤0.01% 910
2017
Q4 		$5K Hold
38
– – ﹤0.01% 955
2017
Q3 		$4K Hold
38
– – ﹤0.01% 976
2017
Q2 		$3K Hold
38
– – ﹤0.01% 1022
2017
Q1 		$3K Buy
38
+7
+23% +$324 ﹤0.01% 1053
2016
Q4 		$1K Sell
31
-20
-39% -$837 ﹤0.01% 983
2016
Q3 		$3K Buy
51
+45
+750% +$3.17K ﹤0.01% 795
2016
Q2 		$0 Buy
+6
New +$378 ﹤0.01% 1007
2016
Q1 		– Sell
-13
Closed -$1K – 1043
2015
Q4 		$1K Buy
+13
New +$1.21K ﹤0.01% 744

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Proficio Capital Partners's ALNY Position: Q4 2025 in Review

Proficio Capital Partners sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2025, closing a stake of 488 shares — an estimated $223K sold.

Proficio Capital Partners first reported a position in ALNY in Q4 2015 and held it in 20 quarters. The position peaked at $384K in Q2 2024. 848 funds tracked by Wall St. Rank hold ALNY as of Q4 2025.

  • Proficio Capital Partners reported no remaining Alnylam Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Proficio Capital Partners sold 488 Alnylam Pharmaceuticals shares in Q4 2025, an estimated $223K.
  • Proficio Capital Partners first reported a position in Alnylam Pharmaceuticals in Q4 2015 and held it in 20 quarters.
  • Proficio Capital Partners's Alnylam Pharmaceuticals position peaked at $384K in Q2 2024.
  • 848 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2025.

Based on Proficio Capital Partners's 13F filing for Q4 2025, filed 12 Feb 2026.